Life Technologies (LIFE) Releases New Research Tool: Oncomine NGS RNA-Seq Gene Expression Browser
4/7/2014 10:18:05 AM
SAN DIEGO--(BUSINESS WIRE)--Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of the prevalent cancer driver events, but cancer transcriptome expression data generated in labs around the world are difficult to collect, combine, and analyze to better understand cancer biology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by